BNP Paribas Financial Markets Reduces Position in Surgery Partners, Inc. (NASDAQ:SGRY)

BNP Paribas Financial Markets lowered its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 83.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,616 shares of the company's stock after selling 84,424 shares during the period. BNP Paribas Financial Markets' holdings in Surgery Partners were worth $536,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Arizona State Retirement System raised its stake in shares of Surgery Partners by 1.9% during the second quarter. Arizona State Retirement System now owns 19,494 shares of the company's stock valued at $464,000 after acquiring an additional 359 shares in the last quarter. Natixis Advisors LLC raised its stake in shares of Surgery Partners by 3.0% during the third quarter. Natixis Advisors LLC now owns 12,828 shares of the company's stock valued at $414,000 after acquiring an additional 376 shares in the last quarter. KBC Group NV raised its stake in shares of Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company's stock valued at $77,000 after acquiring an additional 576 shares in the last quarter. Mackenzie Financial Corp raised its stake in shares of Surgery Partners by 3.4% during the second quarter. Mackenzie Financial Corp now owns 19,999 shares of the company's stock valued at $476,000 after acquiring an additional 662 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC raised its stake in shares of Surgery Partners by 15.9% during the second quarter. MeadowBrook Investment Advisors LLC now owns 12,320 shares of the company's stock valued at $293,000 after acquiring an additional 1,690 shares in the last quarter.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Benchmark reaffirmed a "buy" rating and set a $50.00 price target on shares of Surgery Partners in a research note on Monday, August 26th. UBS Group began coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a "buy" rating and a $38.00 price objective on the stock. JPMorgan Chase & Co. cut their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a report on Tuesday, December 3rd. Cantor Fitzgerald reissued an "overweight" rating and set a $43.00 price objective on shares of Surgery Partners in a report on Friday, October 4th. Finally, Royal Bank of Canada cut their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a report on Wednesday, November 20th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. According to MarketBeat, Surgery Partners presently has a consensus rating of "Moderate Buy" and an average target price of $37.38.

Surgery Partners Stock Up 0.5 %

NASDAQ SGRY traded up $0.11 on Friday, hitting $20.36. The stock had a trading volume of 2,573,112 shares, compared to its average volume of 988,666. The business's fifty day moving average price is $26.93 and its 200 day moving average price is $27.97. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. Surgery Partners, Inc. has a 52-week low of $19.90 and a 52-week high of $36.92. The stock has a market cap of $2.59 billion, a price-to-earnings ratio of -42.42, a price-to-earnings-growth ratio of 17.95 and a beta of 2.58.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to analysts' expectations of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners's revenue for the quarter was up 14.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.15 earnings per share. Equities research analysts anticipate that Surgery Partners, Inc. will post 0.71 earnings per share for the current year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.